Cargando…
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery
Idiopathic pulmonary fibrosis (IPF) affects an increasing number of people globally, yet treatment options remain limited. At present, conventional treatments depending on drug therapy do not show an ideal effect in reversing the lung damage or extending the lives of IPF patients. In recent years, m...
Autores principales: | Sang, Lu, Guo, Xiaoqin, Fan, Haojun, Shi, Jie, Hou, Shike, Lv, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367455/ https://www.ncbi.nlm.nih.gov/pubmed/35954166 http://dx.doi.org/10.3390/cells11152322 |
Ejemplares similares
-
Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
por: Kletukhina, Sevindzh, et al.
Publicado: (2022) -
Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update
por: Sang, Lu, et al.
Publicado: (2021) -
Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics
por: Fujita, Yu
Publicado: (2022) -
How the Pathological Microenvironment Affects the Behavior of Mesenchymal Stem Cells in the Idiopathic Pulmonary Fibrosis
por: Bonifazi, Martina, et al.
Publicado: (2020) -
The Emerging Role of Extracellular Vesicles from Mesenchymal Stem Cells and Macrophages in Pulmonary Fibrosis: Insights into miRNA Delivery
por: Li, Shuang, et al.
Publicado: (2022)